Post-progression survival following second-line chemotherapy in patients with advanced pancreatic cancer previously treated with gemcitabine: a meta-analysis.

导出原文传递

翻译打印收藏纠错

作者： Akiyoshi,Kasuga ^[1] ; Yasuo,Hamamoto ^[2] ; Ayano,Takeuchi ^[3] ; Naohiro,Okano ^[4] ; Kazuhiro,Togasaki ^[2] ; Yu,Aoki ^[2] ; Takeshi,Suzuki ^[2] ; Kenta,Kawasaki ^[2] ; Kenro,Hirata ^[2] ; Yasutaka,Sukawa ^[2] ; Takanori,Kanai ^[2] ; Hiromasa,Takaishi ^[2]

作者单位： Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. akiyoshi_81@hotmail.com. ^[1] Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. ^[2] Department of Preventive Medicine and Public Health, School of Medicine, Keio University, Tokyo, Japan. ^[3] Department of Clinical Oncology, School of Medicine, Kyorin University, Tokyo, Japan. ^[4]

关键词 Meta-analysis Pancreatic cancer Post-progression survival Randomized controlled trial Salvage chemotherapy Second-line chemotherapy

主题词抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);脱氧胞苷(Deoxycytidine);疾病恶化(Disease Progression);人类(Humans);胰腺肿瘤(Pancreatic Neoplasms);随机对照试验(主题)(Randomized Controlled Trials as Topic);存活率分析(Survival Analysis)

DOI 10.1007/s10637-018-0589-6

PMID 29572783

发布时间 2022-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交